Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX).
- Disclosed ownership: 5%.
- Date of event: 15 Apr 2026.
Point72 Asset Management, L.P. - 15 Apr 2026 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- CTMX
- Shares outstanding
- 217,291,620 shares
- Disclosed Ownership
- 10,864,581 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 16 Apr 2026, 16:10:11 UTC
- Date of event
- 15 Apr 2026
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 5% ownership in CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX) on 15 Apr 2026."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 16 Apr 2026, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5% | 10,864,581 | 0 | 10,864,581 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 5% | 10,864,581 | 0 | 10,864,581 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 5% | 10,864,581 | 0 | 10,864,581 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |